NUVOLI, Susanna Maria Francesca
 Distribuzione geografica
Continente #
NA - Nord America 16.401
AS - Asia 9.032
EU - Europa 6.184
SA - Sud America 5.884
AF - Africa 305
OC - Oceania 42
Continente sconosciuto - Info sul continente non disponibili 35
Totale 37.883
Nazione #
US - Stati Uniti d'America 16.064
BR - Brasile 5.262
SG - Singapore 3.929
CN - Cina 2.763
UA - Ucraina 2.049
SE - Svezia 1.037
HK - Hong Kong 955
DE - Germania 930
IT - Italia 750
FI - Finlandia 392
GB - Regno Unito 313
VN - Vietnam 303
AR - Argentina 232
FR - Francia 166
TR - Turchia 160
RU - Federazione Russa 133
BD - Bangladesh 122
CA - Canada 122
IN - India 121
MX - Messico 116
IQ - Iraq 98
UZ - Uzbekistan 98
ZA - Sudafrica 97
EC - Ecuador 82
CO - Colombia 79
VE - Venezuela 72
MA - Marocco 64
KR - Corea 59
PK - Pakistan 58
CZ - Repubblica Ceca 51
JP - Giappone 50
PL - Polonia 48
BE - Belgio 46
ES - Italia 41
PY - Paraguay 40
NL - Olanda 37
AT - Austria 36
AU - Australia 36
TN - Tunisia 36
UY - Uruguay 35
ID - Indonesia 34
AZ - Azerbaigian 32
CL - Cile 31
EU - Europa 29
PE - Perù 29
AE - Emirati Arabi Uniti 28
JO - Giordania 28
IL - Israele 24
RO - Romania 23
KZ - Kazakistan 22
DZ - Algeria 20
KE - Kenya 20
DO - Repubblica Dominicana 19
LT - Lituania 19
NP - Nepal 19
EG - Egitto 18
AL - Albania 17
BO - Bolivia 17
HN - Honduras 17
JM - Giamaica 17
KG - Kirghizistan 17
SA - Arabia Saudita 14
SN - Senegal 13
LB - Libano 12
IE - Irlanda 11
IR - Iran 11
PA - Panama 11
BY - Bielorussia 10
CR - Costa Rica 10
OM - Oman 10
RS - Serbia 10
GE - Georgia 9
BG - Bulgaria 8
PH - Filippine 8
BH - Bahrain 7
GA - Gabon 7
GR - Grecia 7
PS - Palestinian Territory 7
BA - Bosnia-Erzegovina 6
BN - Brunei Darussalam 6
MD - Moldavia 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
TT - Trinidad e Tobago 6
AO - Angola 5
CH - Svizzera 5
PT - Portogallo 5
QA - Qatar 5
SV - El Salvador 5
SY - Repubblica araba siriana 5
XK - ???statistics.table.value.countryCode.XK??? 5
CI - Costa d'Avorio 4
DK - Danimarca 4
GT - Guatemala 4
HU - Ungheria 4
MK - Macedonia 4
ET - Etiopia 3
GH - Ghana 3
GY - Guiana 3
LU - Lussemburgo 3
Totale 37.830
Città #
Dallas 6.265
Chandler 2.105
Singapore 2.061
Jacksonville 1.291
Hong Kong 946
Princeton 689
Dearborn 664
Nanjing 583
Beijing 514
Ashburn 459
New York 364
São Paulo 359
Wilmington 287
Boardman 281
Sassari 242
Shanghai 233
Nanchang 226
Los Angeles 202
Rio de Janeiro 165
Belo Horizonte 153
Shenyang 142
Munich 138
Tianjin 120
Ho Chi Minh City 119
Ann Arbor 114
Brasília 111
Woodbridge 98
Jiaxing 94
Santa Clara 94
Hebei 91
Tashkent 87
Changsha 76
Curitiba 71
Porto Alegre 64
San Francisco 61
Seoul 58
Buffalo 57
Helsinki 56
Goiânia 55
Hanoi 54
Salvador 54
Turku 54
Campinas 52
Guarulhos 49
Hangzhou 49
Kunming 47
Brussels 45
Johannesburg 45
Manaus 45
Tokyo 44
Toronto 42
Warsaw 42
Brno 41
Chicago 41
Cagliari 40
Fortaleza 40
London 40
Montreal 40
Norwalk 40
Baghdad 39
Denver 39
Sorocaba 39
Stockholm 38
Jinan 36
Guangzhou 35
Istanbul 34
Joinville 34
Poplar 34
Buenos Aires 33
Baku 32
Brooklyn 32
Contagem 32
Recife 31
Atlanta 30
Dhaka 30
Ribeirão Preto 30
São José dos Campos 30
Betim 28
Ankara 27
Boston 27
Caxias do Sul 27
Chennai 27
Rome 27
The Dalles 27
Zhengzhou 27
Amman 26
Columbus 26
Council Bluffs 26
Guayaquil 26
Juiz de Fora 26
Mexico City 26
Montevideo 26
Uberlândia 26
Asunción 25
Izmir 25
Milan 25
Osasco 25
Frankfurt am Main 24
Ipatinga 24
Lima 24
Totale 21.904
Nome #
The role of 123I-MIBG cardiac scintigraphy in the patients with movement disorders (MD). 320
The impact of risk factors ascertained at the surgery of the primary tumor on metastasis appearance and outcome of patients with papillary thyroid microcarcinoma (PTMC). 296
123I-ioflupane brain SPECT and 123I-MIBG cardiac planar scintigraphy combined use in uncertain parkinsonian disorders 264
123I-FP-CIT SPECT: a new diagnostic method for Parkinson Disease 253
123I-FP-CIT brain SPECT: tracer uptake values of right putamen are the most discriminant to diagnose Parkinson’s disease. 249
111InPentetreotide SPECT and SPECT/CT in non functioning gastroenteropancreatic neuroendocrine tumors (GEP). 236
111In-pentetreotide SPECT and SPECT/CT vs conventional imaging procedures (CIP) in non-functioning gastroenteropancreatic neuroendocrine tumor (GEP) patient management. 234
(111) In-pentetreotide SPECT/CT in pulmonary carcinoid (PC) 226
(111) In-pentetreotide SPECT/CT in gastroenteropancreatic (GEP) 224
111In pentetreotide SPECT/CT in neuroendocrine tumor (NETs) diagnostic management. 224
123I FP-CIT SPECT and 99mTc HM-PAO SPECT combined use in patients with associated movement and cognitive disorders 214
123I Ioflupane SPECT in the differential diagnosis of Lewy bodies Dementia 210
111In-Pentetreotide SPECT/CT in neuroendocrine gastroenteropancreatic (GEP) tumors 210
123I-FP-CIT SPECT usefulness in early stage Parkinson’s Disease 209
β-Endorphin and Cortisol Levels in Plasma and CSF Following Acute Experimental Spinal Traumas 207
123I FP-CIT SPECT in early Parkinson’s disease 207
123I-FP-CIT brain SPECT data by means of a support vector machine classifier (SVM) to diagnose Parkinson’s disease. 207
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage. 206
Enzyme biosensors for biomedical applications: Strategies for safeguarding analytical performances in biological fluids 199
99mTc-Tetrofosmin Pinhole-SPECT (P-SPECT) and Radioguided sentinel node (SN) biopsy and in breast cancer axillary lymph node staging 194
123I-MetalodoBenzylGuanidine (123I-MIBG) cardiac scintigraphy in the differential diagnosis of neurodegenerative movements disorders 191
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 186
Underserved populations and bacterial and protozoal sexually transmitted infections: a lost health-care opportunity 184
99mTc-tetrofosmin SPET in the detection of both primary breast cancer and axillary lymph node metastasis 178
111In pentetreotide SPECT e SPECT/TC in non fuctioning gastroenteropancreatic tumors (GEP) 176
123I-FP-CIT SPECT in the diagnosis of Parkinson’s disease in early stage 172
A longitudinal Study on body compositionin HIV –infected patients receiving HAART. 169
Epidemiology, Clinical Aspects, Laboratory Diagnosis and Treatment of Rickettsial Diseases in the Mediterranean Area During COVID-19 Pandemic: A Review of the Literature 167
99mTc HM-PAO Brain Spect Qualitative and Quantitative Analyses (QLA/QNA) In Fibromyalgia Syndrome (FMS) Treated With Hyperbaric Oxigen Therapy (HOT) 166
123I-Ioflupane brain SPECT (I-SPECT) and brain parenchyma sonography (BPS) combined use in movement disorder diagnosis 159
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 158
123I-Ioflupane SPECT reduced parental glutathione (GSH) therapy evaluation in Parkinson’s disease (PD) 157
111In-pentetreotide SPECT/CT in neuroendocrine tumors (NETs) 156
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative local staging of primary breast cancer. 156
99mTc-Tetrofosmin scan in non small cell lung cancer (NSCLC) 151
Acute akinetic catatonia in multiple sclerosis: case report and review of literature 150
99mTc-tetrofosmin molecular breast imaging (MBI) with high resolution dedicated breast camera (DBC) and breast dynamic magnetic resonance imaging (MRI) in the preoperative staging of breast cancer: a comparative study. 150
The burden of HIV-Associated neurocognitive disorder (HAND) in post-HAART era: Amultidisciplinary review of the literature 147
The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy 146
123I-MIBG Cardiac Scintigraphy and123I-IOFLUPANE SPECT Combined Use In Uncertain Parkinsonian Syndromes 142
Role of an artificial neural network classifier, a classification tree (ClT), to diagnose Parkinson’s disease in early phase by using 123I-FP-CIT brain SPECT data. 141
Combined 123I-Iofuplane SPECT and 123I-MIBG cardiac scintigraphy use in Parkinson disease(PD) and vascular Parkinsonism(VP) differential diagnosis. 140
99mTc-Tetrofosmin axillary planar, SPECT and Pinhole SPECT (P-SPECT) in breast cancer (BC) non palpable lymph node metastases detection 140
The value of semiquantitative FDG-PET parameters in the diagnosis of solitary pulmonary nodules with pre-test intermediate likelihood of malignancy: a single-centre study 139
18F-FDG PET/CT Usefulness In Primary Progressive Aphasia (PPA) Variants And In Fronto-Temporal Dementia (FTD) Or Alzheimer’s Disease (AD) Development. 138
Cortical metabolic 18F-FDG PET assessment and striatal dopamine transporter SPECT imaging in suspected early neurodegenerative disorders with uncertain movement and cognitive symptoms 137
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study. 135
Neck iodine fixing foci in differentiated thyroid carcinoma (DTC) follow-up patients: a 131 I-SPECT/CT study. 135
Brain 18F-FDG PET/CT usefulness in primary progressive aphasia variant diagnosis and in their development into Alzheimer’s disease or fronto-temporal dementia 134
The usefulness of SPECT/CT and neck pinhole SPECT (P-SPECT) as complementary tools to planar parathyroid scintigraphy in hyperparathyroidism (HPT). 134
18F-FDG PET/CT in patients with autoimmune encephalitis in the early stage. 133
The role of 99mTc-tetrofosmin Pinhole-SPECT in breast cancer axillary lymph node staging 133
99mTc-tetrofosmin SPECT/CT in solitary pulmonary nodule (SPN) evaluation. 133
Body fat changes in HIV patients on highly active antiretroviral therapy (HAART): a longitudinal DEXA study 131
The additional role of 18F-FDG PET/CT in prosthetic valve endocarditis 131
The value of preoperative molecular breast imaging for the size assessment of invasive carcinoma and ductal carcinoma in situ 130
Value of Shape and Texture Features from 18F-FDG PET/CT to Discriminate between Benign and Malignant Solitary Pulmonary Nodules: An Experimental Evaluation 130
Brain 18F-FDG PET qualitative and quantitative analyses in Atypical Parkinsonian Syndromes (APS) with Cognitive Clinical Symptoms (CCS) 129
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 129
123I-MIBG cardiac scintigraphy quantitative analysis in Parkinson’s disease (PD) and Parkinsonisms (P) differential diagnosis: a classification tree (CIT) classifier additional contribute. 128
Body composition change in hiv-infected patients treated with HAART: a longitudinal DEXA study. 127
Qualitative (Q) and semiquantitative (SQ) brain 18FFDG PET analyses in primary progressive aphasia (PPA) variants 126
The classification tree (CIT) classifier applied by 123I-MIBG cardiac scintigraphy in differentiating Parkinson’s disease (PD) from Parkinsonism (P). 125
Body composition evaluation by DEXA in the follow up of HIV patients treted with HAART. 125
The usefulness of SPECT scintimammography in multifocal/multicentric breast cancer detection 124
131I SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC). 124
Tc-99m Tetrofosmin (T) scintigraphy in patients with abdominal cancer 123
123I-MIBG cardiac scintigraphy in discriminating Parkinson’s disease (PD) from vascular Parkinsonism (VP ) using classification tree( CIT ) classifier together with conventional quantitative analysis. 123
Breast scintigraphy with a breast specific gamma camera (BSGC) and dynamic breast magnetic resonance imaging (MRI) in the detection of primary breast cancer (BC): A comparative study 122
The role of Tc-99m Tetrofosmin (T) SPECT in mediastinal lymph node metastasis detection in lung cancer (LC). A.Spanu, F.Ginesu, A.Farris, M.E.Solinas, G.Deiola, C.Bagella, P.Pirina, G.C.Ginesu, S.Nuvoli, P.Solinas and G.Madeddu. Eur J Nucl Med 1997 122
18F-FDG PET/CT in intracranial leptomeningeal carcinomatosis 122
Tc 99m-Tetrofosmin scan in lung and breast cancer detection 122
Intracranial Leptomeningeal Carcinomatosis: A Diagnostic Study with18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography 121
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 121
18F-FDG Brain PET/CT Metabolic Imaging in Patients with Suspected Autoimmune Encephalitis (AE) in the Early Stage: Can the Procedure Play a Complementary Diagnostic Role? 120
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 119
Plasma levels of leptin in heavy obese subjects 118
Caratterizzazione clinica del miocardio ibernato identificato mediante scintigrafia miocardica con Tallio-201. 117
131I-SPECT/CT in differentiating neck iodine fixing foci in patients with differentiated thyroid carcinoma (DTC). 116
Anatomo-histopathological and histometric survey of venninous arteritis caused byStrongylus vulgarisin naturally infected horses in Sardinia (Italy) 116
131I-SPECT/CT usefulness in patients with Hashimoto’s thyroiditis (HT) coexistence with papillary thyroid carcinoma (PC) without risk factors at surgery followed in a long-term follow-up after thyroidectomy and radioiodine ablation 115
Free/Total PSA ratio (F/T) and total (T) PSA combined use in monitoring finasteride (F) treated benign prostatic hyperplasia (BPH) 115
131I-SPECT/CT usefulness in the follow up of patients thyroidectomized for thyroid papillary microcarcinoma ( PTMC). 115
Primary Progressive Aphasia (PPA) variants: a diagnostic brain 18F-FDG PET/CT study 115
99mTc-Tetrofosmin (TF) mammoscintigraphy in primary breast cancer (BC) detection: SPECT vs Planar 114
Alzheimer disease (AD) and Lewy bodies dementia (LBD) differential diagnosis: a 123Ioflupane SPECT study. 114
131I-SPECT/CT in the diagnosis and characterization of metastatic lesions in patients with differentiated thyroid carcinoma (DTC) in chronic follow-up 114
A longitudinal study on bone metabolism in HIV patients treated with HAART. 113
Central nervous system involvement in systemic lupus erythematosus patients as revealed by brain MRI and SPECT. M.Piga, L.Satta, G. Sanna, G.L.Loi, M.Floris, A.Vacca, M.Laudadio, A.Careddu, C.Montaldo, A.Spanu, S.Nuvoli, G.Madeddu, A.Mathieu. Q J Nucl Med 1996, 40 (suppl 1): 18 113
The usefulness of high resolution planar scintimammography with dedicated breast camera in the diagnosis of multifocal/multicentric primary breast cancer (BC) 112
Iodine-123 Ioflupano brain SPECT in extra-pyramidal movement disorders of recent appearance 111
99mTc-tetrofosmin planar scintimammography and SPECT in monitoring the response to neoadjuvant hormone or chemotherapy in locally advanced primary breast cancer (LAPBC) 111
99mTc- tetrofosmin Breast Scintigraphy with breast-specific gamma-camera (BSGC) in breast cancer detection and preoperative local staging: a comparative study with dynamic Magnetic Resonance Imaging (MRI). 111
Impact of Lesion Delineation and Intensity Quantisation on the Stability of Texture Features from Lung Nodules on CT: A Reproducible Study 111
Beta-endorphin and Cortisol Levels in Plasma and CFS Following Acute Experimental Spinal Traumas 111
Breast-specific imaging (BSGI) in predicting tumor response to treatment and in assessing residual tumor size following neoadjuvant therapy in locally advanced primary breast cancer. 110
Scintimammography with dedicated breast camera vs SPECT in breast cancer and axillary lymph node metastasis detection: a preliminary study. 110
Bone Alkaline Phosphatase (BAP) related to Prostate Specific Antigen (PSA) in bone metastasis prostate cancer (PC) patients 109
The role of TC-99m Tetrofosmin SPECT in breast cancer diagnosis, axillary lymph node staging and follow up 109
Random Forest Classifier contribution in the differential diagnosis of movement disorders studied by 123 I-MIBG cardiac scintigraphy. 109
Totale 15.205
Categoria #
all - tutte 147.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 147.737


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.783 0 0 0 0 0 228 344 4 480 467 158 102
2021/20221.479 229 13 19 7 13 17 36 124 126 83 154 658
2022/20234.015 384 198 66 736 427 668 12 504 730 24 179 87
2023/20241.505 252 123 58 59 450 109 6 39 3 24 111 271
2024/202510.965 115 136 615 201 398 295 746 2.435 3.916 1.345 441 322
2025/202611.690 606 4.329 2.613 2.077 1.377 688 0 0 0 0 0 0
Totale 38.194